PRHSX
T. Rowe Price Health Sciences Fund
Mutual fund
$92.87+0.04 (+0.04%)Close Oct 2, 2026
Adjusted price
+25.41% total return, past year
Key statistics
- Net assets
- $12.5B
- Expense ratio
- 0.83%
- Share classes
- 2
- 52-week range
- $75.20$98.96
- From all-time high
- −20.72%
- Max drawdown
- −42.96%
- Volatility
- 20.66%
- Sharpe ratio
- 0.71
- Beta (5Y monthly)
- 0.65
Returns
Total
- 1M
- −3.7%
- YTD
- +11.2%
- 1Y
- +25.4%
Per year
- 3Y
- +13.1%
- 5Y
- +4.3%
- 10Y
- +11.0%
- 20Y
- +13.3%
- Since 1995
- +13.4%
Fund facts
As of Jun 30, 2026- Holdings
- 279
- Top 10 holdings
- 47.6%
- Stocks
- 96.4%
- Preferred stock
- 2.9%
- Cash
- 0.6%
Sectors
- Health Care
- 93.7%
- Consumer Discretionary
- 0.2%
- Information Technology
- 0.1%
- Financials
- 0.0%
- Industrials
- 0.0%
- Not classified
- 5.3%
Top holdings
| Holding | Weight (%) |
|---|---|
| LLYEli Lilly and Company | 14.3 |
| JNJJohnson & Johnson | 6.6 |
| UNHUnitedHealth Group Incorporated | 6.0 |
| ABBVAbbVie Inc. | 5.1 |
| MRKMerck & Co., Inc. | 4.0 |
| GILDGilead Sciences, Inc. | 2.8 |
| TMOThermo Fisher Scientific Inc. | 2.5 |
| VRTXVertex Pharmaceuticals Incorporated | 2.3 |
| BMYBristol-Myers Squibb Company | 2.1 |
| ABTAbbott Laboratories | 1.9 |
Annual returns
1995 from Dec 29 · 2026 through Oct 2